“Covid Solution”
Authors: Menicagli r
Date: 2020
Scope of interest: infectivology
06 99 39
Recup number
You may also be interested in:
Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First ItalianųoRk Study (BRIVAFIRST).
Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Irelli EC, Chiesa V, Dainese F, De Maria G, Didato G, Gennaro GD, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group Membership
Date: 2022
Scope of interest: Epilepsy
Read details
Drug-resistant partial epilepsy, focal cortical dysplasia, continuous spike-wave in sleep: what surgical strategies?
Authors: S. Casciato, , L. Lapenta, J. Fattouch, C. Di Bonaventura, A.E. Vaudano, M. Fanella, A. Morano, L. Lombardi, M. Manfredi, A.T. Giallonardo
Date: 2012
Scope of interest: Epilepsy
Read details
Limbic encephalitis as a model of immune-mediated epilepsies: definition, etiology, electro-clinical features and outcome.
Authors: Morano A, Casciato S, Fattouch J, Fanella M, Albini M, Di Gennaro G, Quarato PP, Mascia A, D’Aniello A, Giallonardo AT, Di Bonaventura C.
Date: 2016
Scope of interest: Epilepsy/autoimmune diseases of the CNS
Read details
What to do to
Click on the icon of the service you are looking for and go to the dedicated section. If the service is not in the selection, go to Service Guide
